Browsing eNauka
Browsing by Project Genentech, Inc.Roche HoldingGenentech
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE). | Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2021 | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC | Jassem, Jacek; ...; Andric, Zoran G   ; ...; (broj, koautora 19) | Article | 21a+M21a+ |